drugset / Trial / NCT02821715
Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients
RandomizedCrossoverQuadruple-blindTreatment
Summary
This Phase 2 study is a 8-site, double-blind, randomised, placebo-controlled, 3-way cross-over trial, involving 3 treatments with Modafinil 300 mg or the combination drug THN102 (Modafinil/Flecainide 300 /3 mg, Modafinil/Flecainide 300 /27 mg).
Timeline
- Start
- 2016-09
- Primary completion
- 2018-12
- Completion
- 2019-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | flecainide | Small molecule | 3 mg | — |
| Subject | flecainide | Small molecule | 27 mg | — |
| Comparator | Modafinil | Small molecule | 300 mg | — |